1.31
Envue Medical Inc stock is traded at $1.31, with a volume of 657.91K.
It is down -10.27% in the last 24 hours and down -63.10% over the past month.
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. It targets safety in ICUs and hospitals while exploring applications in vascular access.
See More
Previous Close:
$1.46
Open:
$1.41
24h Volume:
657.91K
Relative Volume:
1.41
Market Cap:
$1.43M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-43.29%
1M Performance:
-63.10%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Envue Medical Inc Stock (FEED) Company Profile
Name
Envue Medical Inc
Sector
Industry
Phone
(914) 233-3004
Address
969 PRUITT AVE,, TYLER
Compare FEED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
FEED
Envue Medical Inc
|
1.31 | 1.59M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Envue Medical Inc Stock (FEED) Latest News
ENvue Medical, Inc. Rings the Opening Bell - Nasdaq
ENvue Medical (FEED) Introduces Over-the-Counter ENFit Syringes - GuruFocus
ENvue Medical Launches Over-the-Counter ENFit Syringes for Enhanced Enteral Care Solutions - Quiver Quantitative
ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription - marketscreener.com
Reusable tube-feeding syringes now sold online without a prescription - Stock Titan
ENvue Medical announces launch of new development, integration program - Yahoo Finance
ENvue Medical Inc. (FEED) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Envue Medical’s Stock Movement Anticipates Strategic Moves and Market Shifts - StocksToTrade
ENvue Medical to develop vibration tech for nasogastric tube comfort By Investing.com - Investing.com India
ENvue Medical (FEED) Introduces Program for Enhancing NG Tube Co - GuruFocus
ENvue Medical to develop vibration tech for nasogastric tube comfort - Investing.com
ENvue Medical Launches Program to Develop Vibration-Based Technology for Enhanced Comfort in Nasogastric Tube Use - Quiver Quantitative
New program targets pain from nasogastric tubes left in for days - Stock Titan
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 - marketscreener.com
Non-opioid pain device maker marks big milestone in Times Square - Stock Titan
Envue Medical amends long term incentive plan to align with Israeli tax laws - Investing.com
ENvue Medical, Inc.Common Stock (NQ: NAOV - FinancialContent
ENvue Medical, Inc. (FEED) - Zacks Investment Research
Dividend HistoryENvue Medical, Inc. (FEED) - Zacks Investment Research
Total equity of ENvue Medical, Inc. – BOATS:FEED - TradingView — Track All Markets
Total liabilities & shareholders' equities of ENvue Medical, Inc. – NASDAQ:FEED - TradingView — Track All Markets
Total liabilities of ENvue Medical, Inc. – NASDAQ:FEED - TradingView — Track All Markets
NHS adds UroShield Kit to drug tariff, enabling UK-wide reimbursement - Investing.com India
[Form 3] NanoVibronix, Inc. Initial Statement of Beneficial Ownership - Stock Titan
ENvue Medical, Inc. (NAOV) director reports no beneficial ownership on Form 3 - Stock Titan
ENvue Medical (Nasdaq: FEED) details 7.96M-share resale, Series H terms - Stock Titan
UK adds ENvue Medical’s UroShield kit to NHS drug tariff - Investing.com
UK adds ENvue Medical’s UroShield kit to NHS drug tariff By Investing.com - Investing.com South Africa
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK - The Manila Times
ENvue Medical's UroShield® Kit Gains NHS Drug Tariff Inclusion, Expanding Access for Patients in the UK - Quiver Quantitative
UK patients with long-term catheters gain NHS-backed access to new device - Stock Titan
ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK - The Manila Times
FEED Financial Statements & ChartsEnvue Medical Inc MacroTrends - CMLviz
FEEDEnvue Medical Inc Company Profile & Facts - CMLviz
FEED Pivot Points, Technical Analysis and Moving AveragesEnvue Medical Inc Technicals - CMLviz
Why Is ENvue Medical, Inc. (FEED) Stock Down Today? - Meyka
ENvue Medical, Inc. (FEED) Competitors - Meyka
Why Is ENvue Medical, Inc. (FEED) Stock Up Today? - Meyka
ENvue Medical names David Johnson as chairman - Medical Buyer
ENvue Medical Appoints David Johnson as Chairman - citybiz
Envue Medical appoints veteran David Johnson as chairman - marketscreener.com
ENvue Medical (FEED) Appoints David Johnson as Chairman of the B - GuruFocus
ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman - Investing News Network
symbol__ Stock Quote Price and Forecast - CNN
ENvue Medical (NASDAQ: FEED) taps veteran exec David Johnson as chairman - Stock Titan
ENvue Medical Inc (FEED) Stock Earnings Transcripts - GuruFocus
ENvue Medical, Inc. Statistics – BOATS:FEED - TradingView — Track All Markets
ENvue Medical, Inc. Balance Sheet – BOATS:FEED - TradingView — Track All Markets
ENvue Medical, Inc. Revenue Breakdown – BOATS:FEED - TradingView — Track All Markets
ENvue Medical, Inc. (FEED) Return On Equity (TTM) - Zacks Investment Research
ENvue Medical, Inc. (FEED) Return On Assets (TTM) - Zacks Investment Research
Envue Medical Inc Stock (FEED) Financials Data
There is no financial data for Envue Medical Inc (FEED). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):